Selling the assets to Italy’s GVS should help Haemonetics improve its revenue growth and profit margins, analysts said.

By using pre-determined change control plans, manufacturers can update AI-enabled devices without filing an additional FDA ...

I don't think a monopoly market is healthy,” said CMR co-founder Mark Slack, discussing robotic surgery pioneer Intuitive ...

GE Healthcare has identified radiopharmaceuticals as a growth driver for the company and Japan as a key market.

Today, Industry Dive, the company behind MedTech Dive, is combining with TechTarget’s technology websites and Informa Tech’s ...

Millerick, who spent time at Abbott and Alcon, is responsible for defining strategy and driving growth at a J&J business that ...

Composable software seamlessly integrates with core systems, facilitating communication and real-time data sharing between ...

Intera makes a pump and a chemotherapy drug to treat liver tumors. Boston Scientific sees the purchase as a way to provide ...

A prolific medical researcher and author, Martin Makary criticized the FDA and CDC for their decision-making during the ...

The Center for Devices and Radiological Health’s pilot program is meant to cut the time between the FDA’s awareness of ...

CEO Dev Kurdikar said the decision may “come as a surprise” as Embecta just received FDA clearance for a patch pump, but the ...

contextflow’s AI-driven technology enables radiologists to track lung nodules over time, assess malignancy, and generate high ...